tbResList Print — Selenate Selenate

Filters: qv=262, qv2=%, rfv=%

Product

Selenate Selenate
Description: <b>Selenate</b> shares similarity with sulfate and enters cells via sulfate transporters; however, it is less readily reduced and often considered less potent in rapid cytotoxicity effects.<br>
<br>
Selenate tends to exhibit higher IC50 values (often in the 10–100 µM range), indicating reduced potency compared to selenite in directly inducing cancer cell death.<br>
<br>
Less Direct ROS Generation than Selenite.<br>
– Selenate’s toxicity is generally less acute because it is a more inert species until metabolically reduced.<br>
– It may exert its anticancer effects once it is converted into reduced selenium species that eventually can contribute to ROS production.<br>

Pathway results for Effect on Cancer / Diseased Cells

Cell Death

Akt↑, 1,   Apoptosis↑, 1,   Casp↑, 1,   FADD↑, 1,   Fas↑, 1,   FasL↑, 1,  

Transcription & Epigenetics

tumCV↓, 1,  

Cell Cycle & Senescence

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State

EMT↑, 1,  

Migration

E-cadherin↓, 1,   Twist↑, 1,   Vim↑, 1,  
Total Targets: 12

Pathway results for Effect on Normal Cells

Total Targets: 0

Research papers

Year Title Authors PMID Link Flag
2020A novel synthetic chitosan selenate (CS) induces apoptosis in A549 lung cancer cells via the Fas/FasL pathwayJiayue Gao32387597https://pubmed.ncbi.nlm.nih.gov/32387597/0
2013Selenate induces epithelial-mesenchymal transition in a colorectal carcinoma cell line by AKT activationTakanori Tsukamoto23769801https://pubmed.ncbi.nlm.nih.gov/23769801/1